Jane Street Group, LLC Akero Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 217,564 shares of AKRO stock, worth $6.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

217,564

Previous 257,534 15.52%

Holding current value

$6.96 Million

Previous $6.04 Million 3.31%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $857,356 - $1.17 Million	-39,970 Reduced 15.52%	217,564 $6.24 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $136,574 - $183,640	7,459 Added 2.98%	257,534 $6.04 Million
Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $97,218 - $170,679	-5,474 Reduced 2.14%	250,075 $6.32 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $904,857 - $4 Million	79,513 Added 45.17%	255,549 $5.97 Million
Q3 2023 Nov 14, 2023	SELL	$41.19 - $52.25 $3.64 Million - $4.62 Million	-88,390 Reduced 33.43%	176,036 $8.9 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $7.52 Million - $11.6 Million	203,790 Added 336.09%	264,426 $12.3 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $987,505 - $1.33 Million	26,496 Added 77.61%	60,636 $2.32 Million
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $877,331 - $1.44 Million	26,236 Added 331.93%	34,140 $1.87 Million
Q3 2022 Nov 14, 2022	SELL	$10.15 - $34.05 $29,698 - $99,630	-2,926 Reduced 27.02%	7,904 $269,000
Q2 2022 Aug 16, 2022	SELL	$8.0 - $15.01 $126,576 - $237,488	-15,822 Reduced 59.37%	10,830 $102,000
Q1 2022 May 17, 2022	SELL	$12.97 - $22.26 $43,799 - $75,172	-3,377 Reduced 11.25%	26,652 $378,000
Q4 2021 Feb 15, 2022	BUY	$19.87 - $26.24 $119,140 - $157,335	5,996 Added 24.95%	30,029 $635,000
Q3 2021 Nov 16, 2021	BUY	$18.65 - $25.46 $286,333 - $390,887	15,353 Added 176.88%	24,033 $538,000
Q2 2021 Aug 16, 2021	SELL	$24.81 - $32.35 $57,162 - $74,534	-2,304 Reduced 20.98%	8,680 $216,000
Q1 2021 May 18, 2021	BUY	$24.04 - $34.19 $264,055 - $375,542	10,984 New	10,984 $319,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Akero Therapeutics, Inc. Transaction History